Bruker Corporation (BRKR)
Return on equity (ROE)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 427,200 | 296,600 | 277,100 | 157,800 | 197,200 |
Total stockholders’ equity | US$ in thousands | 1,377,200 | 1,113,800 | 1,070,500 | 961,200 | 906,800 |
ROE | 31.02% | 26.63% | 25.89% | 16.42% | 21.75% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $427,200K ÷ $1,377,200K
= 31.02%
Bruker Corp's return on equity (ROE) has shown a positive trend over the past five years. ROE increased from 21.75% in 2019 to 31.02% in 2023, indicating the company's improved ability to generate profits from shareholders' equity. The consistent growth in ROE reflects Bruker Corp's effective management of assets and utilization of equity to generate earnings. This upward trend suggests that the company is efficiently using shareholders' funds to generate profits, which may be attributed to effective strategic decision-making and operational performance. Overall, the increasing ROE indicates a positive financial performance and efficiency in delivering returns to shareholders for Bruker Corp.
Peer comparison
Dec 31, 2023